Confronting the Invincible: Emerging superbug Acinetobacter baumannii endocarditis
Abstract Background Acinetobacter baumannii causing endocarditis, though rare, affects both native and prosthetic valves. Limited clinical data exist, emphasizing the risk of delayed diagnosis and higher mortality in native valve cases. Multidrug resistance and limited therapeutic options make it necessary to adopt tailored strategies for successful management. Case Presentation We report a young male with a history of anabolic steroid and intravenous drug use presented with a week-long history of high-grade fever, jaundice, diminished vision, and shortness of breath. Initial investigations and imaging revealed mitral and aortic valve endocarditis, prompting surgical intervention. Subsequent culture of the vegetation isolated Acinetobacter baumannii and was treated with targeted antibiotic therapy. Conclusions Acinetobacter baumannii is a multidrug-resistant pathogen emerging as a cause of native and prosthetic valve endocarditis. There have only been a few case reports regarding Acinetobacter baumannii. We want to highlight the importance of surgery and culture-guided antibiotics for successful outcomes..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
ResearchSquare.com - (2023) vom: 29. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, Ravi [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.21203/rs.3.rs-3637300/v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XRA041706544 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | XRA041706544 | ||
| 003 | DE-627 | ||
| 005 | 20231130131211.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231130s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21203/rs.3.rs-3637300/v1 |2 doi | |
| 035 | |a (DE-627)XRA041706544 | ||
| 035 | |a (ResearchSquare)10.21203/rs.3.rs-3637300/v1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kumar, Ravi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Confronting the Invincible: Emerging superbug Acinetobacter baumannii endocarditis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Acinetobacter baumannii causing endocarditis, though rare, affects both native and prosthetic valves. Limited clinical data exist, emphasizing the risk of delayed diagnosis and higher mortality in native valve cases. Multidrug resistance and limited therapeutic options make it necessary to adopt tailored strategies for successful management. Case Presentation We report a young male with a history of anabolic steroid and intravenous drug use presented with a week-long history of high-grade fever, jaundice, diminished vision, and shortness of breath. Initial investigations and imaging revealed mitral and aortic valve endocarditis, prompting surgical intervention. Subsequent culture of the vegetation isolated Acinetobacter baumannii and was treated with targeted antibiotic therapy. Conclusions Acinetobacter baumannii is a multidrug-resistant pathogen emerging as a cause of native and prosthetic valve endocarditis. There have only been a few case reports regarding Acinetobacter baumannii. We want to highlight the importance of surgery and culture-guided antibiotics for successful outcomes. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Kattamuri, Lakshmi Prasanna Vaishnavi |4 aut | |
| 700 | 1 | |a Krishna, Sai Vamshi |4 aut | |
| 700 | 1 | |a Soneja, Manish |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2023) vom: 29. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:29 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-3637300/v1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XRA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 29 |c 11 | ||